Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications
Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.313
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Wiley